Profitelligence Profitelligence · Filing Ledger Open MCK research →

Form 8-K · Current Report · Filed 2024-09-10

McKesson Corporation Announces New Notes Offering and Redemption of 2026 Notes

On September 5, 2024, McKesson Corporation announced the issuance of $500 million in 4.250% Notes due 2029 and the redemption of all outstanding 5.250% notes due 2026.

Filer
McKesson Corporation MCK · NYSE
Filed
Accession
0000927653-24-000110
CIK
0000927653
Signal
Medium impactHealthcare

Details

The proceeds from the new notes offering will be used to fund the redemption of the 2026 notes.

Items reported

Item 2.03

Creation of a Direct Financial Obligation

New Debt Issued
Item 8.01

Other Events

Dividend Announced Share Repurchase Program Announced
Item 9.01

Financial Statements and Exhibits

Exhibits Furnished

Market reaction

Close before filing

$509.42

Next session

+0.2%

Since filing

+68.1%

Latest close

$856.19

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from MCK reporting the same item, with the next session's move:

Exhibits (3)

About McKesson Corporation

McKesson Corporation is a leading healthcare services and information technology company. It plays a crucial role in the distribution of pharmaceuticals and medical products. The primary function of McKesson is to ensure the efficient delivery of healthcare products to pharmacies, hospitals, and other medical facilities, ensuring that millions of patients have access to the medications they need. It also provides specialized software and automated solutions that enhance operational efficiency in healthcare sectors. McKesson significantly impacts the pharmaceutical and healthcare industries by offering solutions that streamline supply chains and improve patient care. Its services encompass wholesale drug distribution, healthcare IT systems, and pharmacy management. With operations that extend globally, McKesson is integral to maintaining the integrity and reliability of healthcare supply networks. By handling a substantial portion of the pharmaceutical distribution in North America, McKesson Corporation has a vital market presence, emphasizing its importance in shaping healthcare logistics and innovation. Its efforts contribute to advancing healthcare delivery and responding to the evolving demands of the medical industry.

Exchange NYSE Industry Medical Distribution Company website ↗

Never miss another MCK filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts